Research Topics
| Junya ZhuSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancerJunya Zhu
Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215 5450, USA
Cancer 118:6278-86. 2012....- What constitutes patient safety culture in Chinese hospitals?Junya Zhu
Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215 5450, USA
Int J Qual Health Care 24:250-7. 2012.... - Can we rely on patients' reports of adverse events?Junya Zhu
Center for Patient Safety, Dana Farber Cancer Institute, The Heller School for Social Policy and Management, Brandeis University, Boston, MA 02215 5450, USA
Med Care 49:948-55. 2011..Evidence suggests that patients can report a variety of adverse events (AEs) not captured by traditional methods such as a chart review. Little is known, however, about whether patient reports are useful for measuring patient safety... - Assessing the quality of pain care in ambulatory patients with advanced stage cancerSaul N Weingart
Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
J Pain Symptom Manage 43:1072-81. 2012..Pain is common among patients with advanced cancer despite the dissemination of clinical pain care guidelines... 
Hospitalized patients' participation and its impact on quality of care and patient safetySaul N Weingart
Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
Int J Qual Health Care 23:269-77. 2011..To understand the extent to which hospitalized patients participate in their care, and the association of patient participation with quality of care and patient safety...- US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety StandardsSaul N Weingart
Dana Farber Cancer Institute, Boston, MA
J Oncol Pract 8:7-12. 2012..We sought to assess the implementation status of the ASCO/ONS chemotherapy administration safety standards... - Comparative performance of community health centers and other usual sources of primary careDeborah Gurewich
Schneider Institutes for Health Policy, Brandeis University, Waltham, MA, USA
J Ambul Care Manage 34:380-90. 2011..To determine how Community Health Centers (CHCs) perform relative to other primary care providers... 
Identifying women at risk of delayed breast cancer diagnosisSherri O Stuver
Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
Jt Comm J Qual Patient Saf 37:568-75. 2011..Delays in breast cancer diagnosis contribute to increased morbidity and mortality. Factors related to the occurrence of delayed diagnosis have not been well studied...- Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancerJunya Zhu
Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
JAMA 307:1593-601. 2012..However, longer survival was not observed in the subgroup of patients aged 65 years or older... - Improving electronic oral chemotherapy prescription: can we build a safer system?Saul N Weingart
Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
J Oncol Pract 8:e168-73. 2012..We sought to describe the enhancement, examine its performance to date, and identify opportunities for improvement... - The You CAN campaign: teamwork training for patients and families in ambulatory oncologySaul N Weingart
Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
Jt Comm J Qual Patient Saf 35:63-71. 2009..DISCUSSION: A training program for patients and their families is feasible in ambulatory oncology and may be applicable to other clinical settings...